9th GSCN Conference in Dresden!

„Finally we meet again“
GSCN Conference in Dresden 2021 was a great success

A special event: 300 scientists met in person at the GSCN Conference in Dresden from 6 to 8 October and the atmosphere was characterized by great joy and cordiality to finally meet again in person. The GSCN Conference was a great success: With 6 international keynotes, 68 talks in concurrent sessions, more than 100 posters, 26 industry exhibitors, the GSCN non-PI-meeting and the start of the GSCN Mentoring Program with 5 newly chosen mentees. It was a full and fascinating scientific program.
Next year, the 10th GSCN Conference will take place from 14 – 16 September 2022 in Münster – be part of it and see you there!
More information:  here.

GSCN Awards 2021

The "GSCN 2021 Young Investigator Award" goes to Elvira Mass from the Life and Medical Sciences Institute (LIMES) at the University of Bonn.

The "GSCN 2021 Hilde Mangold Award" goes to Katja Schenke-Layland from the Natural and Medical Sciences Institute at the University of Tübingen.

The "GSCN 2021 Publication of the Year Award" goes to Katharina Scheibner and Heiko Lickert together with Silvia Schirge and Ingo Burtscher from the Institute of Diabetes and Regeneration Research at Helmholtz Zentrum München.

Please read more  here.
Find the press release "Revealing secrets of embryonic development"  here.

New GSCN Mentoring Program

The German Stem Cell Network has succesfully started a one-year GSCN Mentoring Program.
Do you want to become a mentee for 2022/2023? 
Application deadline is the 23 Juli 2022 for the Mentorship 2022/2023.

Please find more information on the program  here

GSCN Annual Magazine 2021


Stem Cell Research and Diseases II

Content: 
- Cardiac replacement therapy
- Stem cells deliver boost to lung research
- Stem cells and immunological memory
- GSCN + BIH = Dialog Platform Stem Cell research
- On the status of brain organoids and embryoids
- and more articles ...

Read it online here (with download link).
Read the German version  here (with download link).

GSCN & BIH initiate "Dialog Platform Stem Cell Research"

Starting in 2021, the German Stem Cell Network (GSCN) and the Berlin Institute of Health (BIH) have entered into a close cooperation with the foundation of the "Dialog Platform Stem Cell Research".
Find the press release with more information here.

Organoids - from stem cells to future technologies

   

Through this White Paper, the GSCN and the Interdisciplinary  Research Group (IAG) Gene Technology Report of the Berlin-Brandenburg Academy of Sciences and Humanities (BBAW) hope to raise public awareness of this research field and stimulate an interdisciplinary public debate on organoids.
Read more

Stem Cells for Life - GSCN Exhibition

The GSCN has developed an exhibition for institutes, universities and teachers - 10 posters on topics of current stem cell research like diabetes, organoids, skin, ethics and many more. Each poster is accompanied by a website with videos, factsheets and an interactive quiz to deepen the information.
Link to the website in German: Stammzellen - Zellen fürs Leben
Link to the website in English: Stem Cells for Life
Contact: gscn.office@mdc-berlin.de

Excellent research: GSCN Award Winners 2020 

The „GSCN 2020 Young Investigator Award“ goes to Prof. Dr. Barbara Treutlein of the Max Planck Institute of Evolutionary Anthropolgy, Leipzig, and the Department of Biosystems Science and Engineering at the ETH Zurich, Switzerland.
The „GSCN 2020 Female Scientist Award“ goes to Prof. Dr. Edith Heard, Director General of the European Molecular Biology Laboratory (EMBL) in Heidelberg.
The „GSCN 2020 Publication of the Year Award“ goes to Sergiy Velychko and Prof. Dr. Hans R. Schöler of the Max Planck Institute for Molecular Biomedicine in Munster.
Find the GSCN press release here:  Development of stem cells in the laboratory
Read more here.

Statement of the GSCN

Offers of unproven stem cell therapies for COVID-19 disease caused by the corona virus SARS-CoV-2

With the spreading COVID-19 pandemic, there is an urgent need for new treatments, especially for critically ill patients. Clinical trials, such as experiments with SARS-COV-2 vaccines, are in full swing. However, there is a significant increase in unproven and untested therapies worldwide, including unproven treatments based on "stem cells". The German Stem Cell Network (GSCN) as well as international scientific societies such as EuroStemCell (Statement), the International Society for Stem Cell Research (ISSCR Statement) and the International Society for Cell & Gene Therapy (ISCT Statement) strongly oppose the irresponsible offer of unproven cell-based treatments, especially in the context of such a severe pandemic. Affected individuals and families are urged to talk to healthcare professionals to obtain the best available information on COVID-19 disease and treatment options.


Members
Active Bioscience
Berlin-Brandenburger Center for Regenerative Therapies (BCRT)
AMSBIO
SFB 873, Centre for Organismal Studies (COS)
BioLamina AB
Center for Regenerative Therapies Dresden (CRTD)
Biological Industries
German Cancer Research Center (DKFZ)
Biopharma Excellence
ForInter
bit.bio
Fraunhofer Institute for Production Technology (IPT)
Eppendorf AG
Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP)
denovoMATRIX
HI-STEM - Heidelberg Institute for Stem Cell Technology and experimental Medicine
iotaSciences
Helmholtz Zentrum München (HMGU)
Miltenyi Biotec
Institute of Reconstructive Neurobiology
NIPPON GENETICS EUROPE GmbH
ISAR Bioscience
OLS - OMNI Life Science
Leibniz Institute on Aging/Fritz Lipmann Institute (FLI)
PELOBiotech GmbH
Leibniz Institute for Zoo and Wildlife Research
PeproTech GmbH
Max Delbrück Center for Molecular Medicine Berlin-Buch (MDC)
Proteintech Group
Max Planck Institute for Heart and Lung Research
RheinCell
Max-Planck-Institute for Molecular Genetics
Takara Bio SAS
Rebirth Cluster of Excellence
Thermo Fisher Scientific - LSG
Tissue Engineering and Regenerative Medicine
Vita34
Deutsche Gesellschaft für Transfusionsmedizin und Immunhämatologie
9th GSCN Conference
Send an e-mail
GSCN on Facebook
GSCN Humhub
GSCN on Twitter

GSCN White Paper on Translation
 

GSCN White Paper Funding
From the Press

Unter die Haut der Zuckerkranken: Stammzell-Implantate produzieren Insulin (GSCN) (DE)
Source: Tagesspiegel.de, 03.12.2021

Stem cell-based implants successfully secrete insulin in patients with type 1 diabetes
Source: sciencedaily.com, 02.12.2021

Human blastoids model blastocyst development and implantation
Source: Nature.com, 02.12.2021

A cure for Type 1 Diabetes?
Source: New York Times, 28.11.2021

Stem cell microbots travel from nose to brain to treat disease
Source: Newatlas.com, 22.11.2021

Stem cell therapy for heart failure reduced major CV events and death, not hospitalization
Source: EurekAlert, 15.11.2021

Audio: Stammzellenforschung - Schon reif für die Klinik? Interview mit D. Besser(GSCN)(DE)
Source: Deutschlandfunkkultur.de, 11.11.2021

Bioethicist Leigh Turner on the worrisome boom in unregulated stem cell clinics
Source: STATnews.org, 08.11.2021

Sara Wickström appointed new director at the Max Planck Institute for Molecular Biomedicine
Source: MPI for Molecular Biomedicine, 02.11.2021

Gene-edited stem cells help geckos regrow more perfect tails
Source: Sciencenews.org, 01.11.2021

Die Teilung des Unteilbaren: Herzregeneration nach genetischer Umprogrammierung von Herzmuskelzellen möglich (DE) (GSCN)
Source: Max Planck Institut Herz- und Lungenforschung, 24.09.2021

Epigenetic changes in aging stem cells rejuvenated by acetate
Source: genengnews.org, 15.09.2021

Zell-Feng Shui: Wie die Einheit von physikalischen und biochemischen Reizen gesunde Organismen ermöglicht (DE)
Source: idw-online.de, 01.09.2021

What’s next for lab-grown human embryos?
Source: nature.com, 31.08.2001

Scientists Grew Stem Cell 'Mini Brains'. Then, The Brains Sort-of Developed Eyes (GSCN)
Source: sciencealert, 18.08.2021

students at laboratory
students at auditorium